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Abstract 
Objective 
To examine the application, design and analysis characteristics of controlled before-after (CBA) and 
interrupted time series (ITS) studies and their use in Cochrane reviews. 
Study Design and Setting  
We searched the Cochrane library for reviews including these study designs from May 2012 - March 
2015 and purposively selected, where available, two reviews each across ten pre-specified 
intervention types. We randomly selected two CBA and two ITS studies from each review. Two 
researchers independently extracted information from the studies and the respective reviews.  
Results 
69 reviews considered CBA and ITS studies for inclusion. We analysed 21 CBA and 16 ITS studies from 
11 and 8 reviews respectively. Cochrane reviews inconsistently defined and labelled CBA and ITS 
studies. Many studies did not meet the Cochrane definition or the minimum criteria provided by 
Cochrane EPOC. The studies present a heterogeneous set of study features and applied a large 
variety of analyses.  
Conclusion 
While CBA and ITS studies represent important study designs to evaluate the effects of interventions, 
especially on a population or organisational level, unclear study design features challenge 
unequivocal classification and appropriate use. We discuss options for more specific definitions and 
explicit criteria for CBA and ITS studies. 
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What is new? 
• CBA and ITS studies are increasingly used but inconsistently labelled and defined in 
Cochrane reviews. 
• Variable definitions and unclear key characteristics challenge their identification and 
classification as well as distinction from other study designs. 
• We detail and explain CBA and ITS study characteristics and propose steps towards a 
consensus process to define key characteristics of these two study designs  
1. Introduction 
One key element of evidence-informed healthcare and public health is that treatment and policy 
decisions are informed by the best available scientific evidence [1]. Decisions are ideally guided by 
well-conducted systematic reviews that gather evidence from well-conducted primary studies to 
assess whether an intervention is more effective and preferably also less costly than another 
intervention.  
Interventions in the field of public health, health services, health systems and health policy tend to 
be more difficult to evaluate than clinical interventions [2-4].  In these fields especially, it may not be 
possible to conduct randomised controlled trials (RCTs) for reasons of feasibility (e.g. interventions to 
reduce ambient air pollution [5]), ethical considerations  (e.g. home-based palliative care [6]) or lack 
of political will [7]. Consequently, assessments of effectiveness in such cases often have to rely on 
nonrandomised studies [8, 9]. Among these, interrupted time series (ITS) and controlled before-after 
(CBA) studies are the study designs most commonly included in Cochrane reviews [10].  
A CBA study is defined in the Cochrane Handbook as a study in which observations are made before 
and after the implementation of an intervention, both in a group that receives the intervention and 
in a control group that does not [11]. The Cochrane Effective Practice and Organisation of Care 
(EPOC) Group, based on a long experience in considering nonrandomised studies, has developed 
criteria for inclusion of CBA studies in systematic reviews, to ensure a minimum level of 
methodological rigour [12]. They recommend at least two intervention sites and two control sites 
[12], as well as contemporaneous data collection [13].  
While the methodological literature on CBA studies is limited, there is disagreement as to whether a 
key characteristic of a CBA study is that the investigator has no control over the intervention 
allocation [11, 12, 14, 15]. Incoherent use of terminology leads to a lack of differentiation between 
features of CBA studies and other study designs, such as nonrandomised controlled trials (NRCTS) [8, 
10, 15, 16].  
An ITS study is defined in the Cochrane Handbook as a study that uses observations at multiple time 
points before and after an intervention (the ‘interruption’). The design attempts to detect whether 
the intervention has had an effect significantly greater than any underlying trend over time [11, 12]. 
The study is frequently conducted retrospectively using routine data [17, 18] and usually, there is no 
investigator control over the allocation of the intervention [11, 12]. Cochrane EPOC specify minimum 
criteria that ITS studies must use at least three data points before and three after the intervention, 
and clearly define the point in time when the intervention occurred [12].  
Several papers have examined the use of ITS studies in health research with respect to 
methodological aspects [16, 19-24]. It was noteworthy that ITS studies applied inappropriate 
methods for statistical analysis, which led to the frequent judgment of statistically non-significant 
effects as significant [19].  
Clarity about CBA and ITS studies in terms of design, data collection and data analysis would be 
helpful for researchers wishing to conduct a CBA or ITS study and facilitate a common terminology. 
Likewise, improved knowledge and transparency about these study designs would make it easier to 
search for and include these study designs in systematic reviews [25]. Ultimately, decision makers 
will have more certainty to recommend for or against an intervention based on studies that generate 
valid findings [26].  
The objective of this study was therefore to examine the application, design and analysis 
characteristics of CBA and ITS studies included in Cochrane reviews. We based our analysis on the 
Cochrane database because it is a generally accepted point of reference for evidence-informed 
decision-making in health and because it applies relatively homogenous standards in terms of study 
design terminology.  
Primary question: 
What are the characteristics of CBA and ITS studies included in Cochrane reviews in terms of design, 
conduct and analysis? 
Secondary questions: 
Which types of interventions are assessed by Cochrane reviews that consider and identify CBA and 
ITS studies? How are CBA and ITS studies defined by review authors? How are CBA and ITS studies (as 
defined by Cochrane authors) defined and labelled by primary study authors? 
2. Methods 
2.1. Identification and analysis of systematic reviews including CBA 
and ITS studies 
Ijaz et al. (2014) documented the use of CBA and ITS studies as well as other nonrandomised studies 
in Cochrane reviews up to May 2012 [10]. As we expected the conduct of CBA and ITS studies in 
primary research as well as their inclusion in systematic reviews to have increased in recent years we 
updated the search by Ijaz et al (2014) replicating their methods. An a priori protocol of our study is 
available online. Our search sought to identify reviews published between May 2012 and March 
2015, whose authors explicitly used the terms “controlled before-after” or CBA and “interrupted 
time series” or ITS studies (i.e. merely “before-after studies” or “time series” were excluded). 
For all reviews including nonrandomised studies, one author (SP) extracted information with cross-
checks performed by two further authors (EAR and DP). Information was extracted on (i) type of 
study designs included and number of studies identified for each type; (ii) responsible Cochrane 
Group; (iii) definition of CBA and/or ITS study by review authors; (iv) risk of bias/quality appraisal tool 
and assessment used by review authors (v) level of intervention (i.e. population, organisational and 
individual level) and (vi) type of health intervention. While descriptions and definitions are often 
used interchangeably, reviews may state criteria without a clear notion of the features of the study 
design they refer to. This is why we also specifically examined whether reviews provided definitions.  
We pre-specified and defined ten intervention types. We based this on a previous publication, where 
we had made a first pragmatic attempt towards a classification of public health interventions [4]. 
These included behavioural/educational, clinical, environmental, health policy, health system, 
nutrition, occupational, pharmaceutical, screening, and vaccination interventions (see Appendix A for 
definitions). We examined the labelling and descriptions of CBA and ITS studies as well as their 
applications to different intervention types across the included reviews.   
2.2. Selection and analysis of CBA and ITS studies 
As we were interested in obtaining insights regarding the use of CBA and ITS studies across different 
areas of health, we purposively selected two reviews per intervention type from those reviews that 
had included at least two CBA or two ITS studies. A minimum of two studies was considered 
important to ensure a reasonable applicability of the study designs to a given intervention type and a 
minimum degree of representativeness in study conduct. For those intervention types, where we had 
to choose among several options (e.g. health systems), we chose reviews from different Cochrane 
groups and assessing different interventions. For each selected systematic review, we randomly 
selected two studies, using an online random choice generator [27]. We undertook the selection 
process separately for CBA and ITS studies. 
For the selected CBA and ITS studies two authors (SP, JB, AF, DP, TM, CR, JPTH, EAR, LMP) 
independently extracted information onto a data extraction form that was specifically developed for 
the purposes of this study and pre-tested in five studies. The data extraction form considered (i) 
publication characteristics (i.e. year of publication, journal, country of study, language of study, 
funding source, terminology/labelling and definitions); (ii) application characteristics (i.e. study 
objective, population, intervention, comparison and outcome, type of intervention, level of 
intervention); and (iii) methodological characteristics covering study design (e.g. setting, control, 
allocation, temporal design), data collection (e.g. number of measurements, outcome assessments, 
source of data, timing) and data analysis (e.g. statistical methods, unit of analysis) and reported 
strengths and weaknesses of study design. Results were compared to achieve consensus, and 
uncertainties and discrepancies were extensively discussed, if necessary with the whole author team. 
Using the extracted data across studies, we assembled information on how CBA and ITS studies were 
defined by primary study authors and, comparing design and analysis features, attempted to define 
key characteristics of both study designs. 
3. Results 
3.1 Identification and analysis of systematic reviews 
For the period May 2012 to March 2015 we found 136 Cochrane reviews (4.8% of a total of 2861 
Cochrane reviews published in this time period) that considered nonrandomised studies for inclusion 
(Supplemental Table 1). The 136 reviews included a total of 1956 studies; the most prevalent study 
designs according to the labels employed by review authors are listed in Table 1. 19 reviews 
identified no studies for inclusion. 
Table 1. Study designs among the 1956 studies included in Cochrane reviews that considered nonrandomised studies 
according to the labels employed by review authors (May 2012 - March 2015) 
Label Number (percentage) 
RCTs  597 (31%) 
cohort studies  166 (9%) 
CBA  168 (9%) 
ITS  143 (7%) 
cross-sectional studies  109 (6%) 
controlled clinical trials (CCT)  91 (5%) 
uncontrolled before-after studies 76 (4%) 
observational studies  75 (4%) 
Cluster RCT 65 (3%) 
Case control 60 (3%) 
Retrospective cohort studies 55 (3%) 
NRCT 42 (2%) 
Prospective controlled cohort studies 26 (1%) 
Prospective cohort studies 25 (1%) 
 
Sixty-nine of the reviews explicitly considered CBA and ITS studies for inclusion (see Appendix B for a 
complete reference list). Among these, 18 reviews identified at least two CBA studies (range: 2-30 
CBA studies) and 16 reviews identified at least two ITS studies (range: 2-52 ITS studies). Altogether, 
twelve reviews identified both CBA and ITS studies. Additionally, five and three reviews identified 
only one CBA and ITS study, respectively.  
3.1.1. Which types of interventions are assessed by Cochrane reviews 
that consider and identify CBA and ITS studies? 
In our sample of 69 reviews, CBA and ITS studies were most widely considered in reviews of health 
system interventions (n=36), followed by reviews of behavioural (n=8), environmental (n=6), 
occupational (n=5), clinical (n=5), and health policy (n=4) interventions. They were rarely, or not at all 
considered in reviews of vaccination, screening, pharmaceutical or nutrition interventions. Among 
the reviews considering CBA and ITS studies, twelve were targeting the population, 43 the 
organisational and 14 the individual level. Tables 2 and 3 show how CBA and ITS studies have 
recently been applied in reviews that actually identified these study designs, suggesting that both 
study designs are most frequent in reviews of health system interventions directed at an 
organisational level. We included CBA and ITS studies that derived from the same reviews [28, 29].  
Table 2. Characteristics of reviews including CBA studies according to intervention type, level, responsible Cochrane 
Group and number of studies identified (May 2012 – March 2015) 
Intervention type 
(number of reviews) 
Cochrane Group* 
(number of reviews) 
Population 
level 
Organisational 
level 
Individual 
level 
Number of 
CBA studies 
Health systems 
(11) 
EPOC (6) 
Injuries (1) 
OSH (3) 
PH (1) 
 11  42 
Behavioural  
(3) 
Injuries (1) 
DA (1) 
PH (1 
2 1  32 
Health policy 
(1) 
OSH (1) 
 
 1  3 
Environmental 
(2) 
PH (1) 
ARI (1) 
1 1  13 
Occupational  
(2) 
Injuries (1) 
OSH (1) 
 2  20 
Clinical  
(1) 
PAPAS (1)   1 2 
Nutrition 
(1) 
DPLP (1)   1 11 
Screening 
(1) 
PAPAS (1)  1  2 
Pharmaceutical, 
Vaccination 
(0) 
 -    - 
* ARI = Acute Respiratory Infections, DA = Drugs and Alcohol, DPLP = Developmental, Psychosocial and Learning Problems, 
EPOC = Effective Practice and Organisation of Care, OSH = Occupational Safety and Health, PH = Public Health, PAPAS = 
Pain, Palliative and Supportive Care.  
Table 3. Characteristics of reviews including ITS studies in terms of intervention type, level, responsible Cochrane Group 
and number of studies identified (May 2012 – March 2015) 
Intervention type 
(number of reviews) 
Cochrane Group* 
(number of 
reviews 
Population 
level 
Organisati
onal level 
Individual 
level 
Number  of 
ITS studies 
Health systems 
(10) 
EPOC (8) 
OSH (1) 
PH (1)  
 10  93 
Behavioural  
(3) 
DA (1) 
EPOC (1) 
TA (1) 
3   32 
Health policy 
(4) 
DA (1) 
EPOC (1) 
OSH (1) 
PH (1) 
2 2  23 
Occupational (2) Injuries (1) 
OSH (1) 
 2  14 
Clinical, environmental, 
nutrition, 
pharmaceutical, 
screening, vaccination (0) 
- - - - - 
* ARI = Acute Respiratory Infections, DA = Drugs and Alcohol, DPLP = Developmental, Psychosocial and Learning Problems, 
EPOC = Effective Practice and Organisation of Care, OSH = Occupational Safety and Health, PH = Public Health, PAPAS = 
Pain, Palliative and Supportive Care, TA = Tobacco Addiction. 
3.1.2. How are CBA and ITS studies defined by review authors? 
About a third of the 69 reviews considering both CBA and ITS studies reported the EPOC criteria of 
two intervention and two control sites (43%) for CBA studies and three data points before and three 
after intervention and a clearly defined intervention time point (36%), respectively, for ITS studies 
(Fig. 1). For CBA studies, many also referred to ‘contemporaneous data collection’ and/or ‘an 
appropriate choice of control’; the need for ‘same time periods before and after the intervention’ 
was also specified repeatedly. For ITS studies, 25% of reviews described one of the two EPOC criteria, 
mostly omitting a clearly defined intervention time point. Less than a tenth of all reviews (4% for CBA 
and 7% for ITS studies) referred to EPOC criteria for CBA or ITS studies without stating them. 
Among the seven reviews that provide specific definitions for CBA studies, two reported the 
Cochrane Handbook definition [11] together with the EPOC criteria [30, 31], another two referred to 
“prospective cohort studies” [32, 33]. Four of the five reviews that provided definitions for ITS 
studies reported them together with the EPOC criteria. Two reviews explicitly referred to the 
Cochrane Handbook definition for ITS studies [30, 31].  
 
Figure 1. Criteria for CBA and ITS studies as used in Cochrane reviews 
3.2. Selection and analysis of primary studies 
For the analysis of CBA studies we purposively selected eleven reviews, covering two reviews each 
for behavioural, environmental, health policy and health system interventions and one review each 
for nutrition, occupational, and screening interventions. Among the 22 CBA studies we randomly 
selected from these reviews, one study (from the screening review) was excluded post selection due 
to an initial misclassification (i.e. it was identified as a CBA study at abstract level but the review 
authors labelled the study in the risk of bias assessment as a CCT) [34]. For the analysis of ITS studies, 
we selected eight reviews, two each concerned with behavioural, health policy, health system and 
occupational interventions. Random selection of two studies from each review yielded 16 ITS studies.  
3.2.1. How are CBA and ITS studies labelled or defined by primary study 
authors?  
Primary study authors did not label any study “CBA”. The descriptions of CBA labels shown in Table 4 
were often mentioned in combination with “before and after the intervention”. Primary study 
authors labelled their study as an “ITS” in only one study. All other studies used various descriptions 
with “time series” mentioned most often in combination with “analysis” or “design”. None of the 
included studies gave a definition of the study design. 
  
43 (62%) provide criteria or 
definitions 
50 (72%) provide 
criteria or 
definitions 
CBA studies (from 69 reviews) ITS studies (from 69 reviews) 
26 (38%) do not provide 
any criteria or definitions 
19 (28%) do not 
provide any 
criteria or 
definitions 
18 (26%) provide EPOC criterion of 2 intervention and 2 
control sites 
25 (36%) provide EPOC criteria for ITS 
studies: 3 data points before and 3 after 
intervention and a clearly defined 
intervention time point 
17 (25%) provide incomplete EPOC 
criteria 
7 (10%) give definition 
3 (4%) refer to EPOC criteria without describing these 
5 (7%) give definition 
3 (4%) refer to EPOC criteria without 
describing these 
5 (7%) provide other information or criteria 
10 (17%) provide more criteria, i.e. 2 intervention and 2 
control sites + “contemporaneous data collection” and/or 
“same pre- and post-intervention periods” and/or 
“appropriate choice of control” 
Table 4. Labels of CBA and ITS studies in primary studies 
CBA labels ITS labels 
“quasi-experimental” (n=5) “time series analysis/design” (n=5) 
“survey” (n=4) “observational” (n=3) 
“comparative study” (n=3) “analysis” (n=3) 
“observational” (n=2) “difference-in-difference” (n=2) 
“cross-sectional” (n=2) “retrospective” (n=2) 
“natural experimental” (n=2) “surveys” (n=1) 
“case-control” (n=1) “interrupted time series” (n=1) 
“prospective cohort” (n=1) “natural experimental research” 
(n=1) 
“difference-in-difference” (n=1)  
 
3.2.2. What are the characteristics of CBA and ITS studies included in 
Cochrane reviews in terms of design, conduct and analysis? 
CBA studies 
Among the 21 selected CBA studies, five were not CBA studies according to the Cochrane definition 
(Fig. 2) because they lacked control sites [35, 36] or measurements before the intervention [37-39]; 
in one study hospital units were randomised into control and intervention group and we therefore 
classified it as a cluster-RCT [40]. Of the 16 actual CBA studies, nine fulfilled the EPOC criteria (i.e. two 
intervention and two control sites, contemporaneous data collection). Compared to the Cochrane 
Handbook, Cochrane EPOC provides a more specific definition of a CBA study where the investigators 
do not have control over the intervention allocation. If we adopt this more specific definition, of the 
selected 16 CBA studies, six complied with both the EPOC definition and criteria. 
Table 5 presents a selection of further study design and analysis characteristics (see Supplemental 
Table 2 for an extended version). There was approximately equal use of CBA studies undertaken in a 
prospective or retrospective manner. We defined retrospective as a study, in which outcome data 
collected prior to the study period are used. In contrast, prospective studies collect outcome data 
during the study period. Defining studies as retrospective or prospective was, however, quite 
challenging [8] and judgments may vary. For about half of the selected studies, allocation of the 
intervention was not controlled by the investigators. The median number of sites among studies 
classified as EPOC CBA studies according to design was 7.5 (range: 3-748) for intervention and 5 
(range: 3-8301) for control sites. In some cases the definition of “sites” was unclear and appeared to 
be synonymous with individuals (e.g. [41]). Study authors used a variety of mostly inappropriate or 
inefficient statistical analysis methods. Many studies applied simple statistical analysis methods, such 
as simple t-tests and did not take clustering into account, leading to unit of analysis errors and 
imprecision of confidence intervals. Studies performed, for example, a simple before and after 
comparison in the intervention group only or compared post-means of individually aggregated data 
into intervention and control group. 
 Figure 2. EPOC criteria assessment for CBA and ITS studies   
 
ITS studies 
Of the 16 selected ITS studies, two did not meet the Cochrane definition, as they did not include any 
data before the intervention [42, 43] (Fig. 2). Of the 14 actual ITS studies, one did not comply with 
the EPOC criteria (i.e. at least three data points before and after the interruption and a clearly 
defined intervention time point), due to an insufficient number of data points before the 
intervention. Of the 13 ITS studies complying with EPOC design criteria, five did not perform a 
statistical analysis and merely displayed the results graphically or reported means before and after 
the intervention. We identified one study, where the intervention was under control of the 
investigators [44]. This study was, however, different in many ways, as the review authors lumped 
together several “meth studies” [35, 44] and included them as a single ITS study [28].  
As shown in Table 6 (see Supplemental Table 3 for an extended version), one study applied 
autoregressive integrated moving average (ARIMA) and at least two studies applied segmented 
regression analysis, although bad reporting impeded a clear identification. A majority of studies 
conducted some form of regression analysis and some adjusted or tested for auto-correlation (n=6) 
and/or reported to adjust for secular trend (n=6). Eight ITS studies [43, 45-52] from five reviews were 
re-analysed by review authors as recommended by EPOC in case of an inappropriate analysis. For ITS 
studies adhering to EPOC design criteria the median number of data points was 12 (range: 3-46) 
before and 12 (range: 3-86) after the intervention. Three studies had a control group and we 
therefore classified them as controlled ITS studies [52-54]. All studies were conducted 
retrospectively.  
15 CBA 6 not CBA 
21 “CBA” 
6 non-EPOC 
CBA  
9 EPOC CBA  
Cochrane 
definition 
Description 
EPOC criteria  
14 ITS 2 not ITS 
16 “ITS” 
1 non-EPOC 
ITS  
13 EPOC ITS  
 
Table 5 CBA study characteristics 
Study ID    Study conduct   
 Interventio
n assessed 
Contemp. 
data 
collection 
Appropriat
e control 
Temporalit
y 
Intervention 
allocation 
outside of 
researcher 
control 
No. of int. 
sites 
No. of 
control 
sites 
Unit of 
allocation 
Georgia 
Meth 2011  
Awareness 
campaign 
against 
drug use  
Na Na Retr. Yes 1 0 State 
Miller 2000 Alcohol and 
Drug Abuse 
Prevention 
Program 
Probably 
yes 
Probably 
no 
Prosp. No 1 1 School 
Pasco 2012 Gatekeeper 
training 
program 
for suicide 
prevention  
Unclear Probably 
no 
Prosp. No 1 0 Individual 
Tompkins 
2009 
Gatekeeper 
training 
program on 
suicide 
prevention 
Probably 
no 
Probably 
yes 
Prosp. No 2 or 3 
(unclear) 
3 School 
Butala 
2010 
Slum 
upgrading 
interventio
n 
Probably 
yes 
Probably 
yes 
Retr. Yes 14 NR Community 
Taylor 1987 Shelter 
upgrading 
for the 
urban poor  
Probably 
yes 
Probably 
no 
Retr Yes NR but 
likely >2 
NR but 
likely >2 
Community 
Meklin 
2005b 
Moisture 
and mould 
renovations  
No No Prosp. No 2 2 School 
Shortt 2007 Housing 
interventio
n (energy 
efficiency 
measures)  
Unclear No Prosp. No 54 46 Household 
Levine 
2012 
Safety 
inspections 
in hospital 
on injuries 
and job loss 
Unclear Unclear Retr Yes 409 409 Company 
Nelson 
1997 
Inspections 
and citation 
for 
violating 
fall 
prevention 
rules 
Yes Unclear Retr Yes 784 8301 Company 
Tucker 
2006 
Classroom 
sexual 
health 
education 
and drop-in 
clinics 
Yes Probably 
yes 
Prosp. Yes 10 5 School 
Hultberg 
2005  
Co-financed 
collaboratio
n model of 
primary 
care  
Probably 
yes 
Probably 
yes 
Prosp. Yes 3 4 Other: city 
area 
Kaushal 
2008 
Unit-based 
clinical 
pharmacist
s to reduce 
medication 
errors 
Yes Probably 
yes 
Prosp. No 3 3 Hospital 
unit 
Morriss 
2009 
A barcode 
scanning 
system for 
Probably 
yes 
Probably 
yes 
Prosp. No 1 1 NICU 
section 
administrat
ing 
medication  
Coyne 1980 Preschool 
meals at 
schools 
(food 
programme
)  
Yes Probably 
yes 
Prosp. Yes 5 5 Community 
Santos 
2005 
Food 
supplement
ation 
programme 
(Milk 
Program)  
Yes Probably 
yes 
Prosp. Yes 10 10 Community 
Maizlish 
1995 
Targeted 
and active 
surveillance 
model for 
health care 
providers  
Unclear Unclear Prosp. Yes 10 NR Hospital 
Smits 2008 In-company 
workshop 
on the 
reporting of 
occupation
al diseases 
Probably 
yes 
Probably 
yes 
Prosp. No NR but 
likely > 2 
NR but 
likely > 2 
Individual  
Meyer 
1993 
Detailed 
follow-up 
(DFU) 
audiometri
c 
examinatio
ns on air 
force 
employees  
Na Na Retr Yes 1 1 (same) Patient 
Nilsson 
1980 
Employees 
wearing ear 
muffs  
Na Na Retr Yes 1 1 (same) Individual 
Jordan 
2003 
Application 
of the 
nursing 
nutritional 
screening 
tool  
Yes Probably 
yes 
Prosp. No 1 1 Hospital 
unit 
Abbreviations: retr.=retrospective, prosp.=prospective, NR=not reported, Na=not applicable 
Table 6 ITS study characteristics 
Study ID  Study conduct Study analysis according to primary study 
authors 
 Intervention 
assessed 
Clear 
interven
tion 
time 
point 
Data 
points 
before 
Data 
points 
after  
Time 
period 
data 
point 
Contr
ol 
group 
Analysis 
characteri
stics 
included 
Reported analysis method 
Grooten
dorst 
2005 
Reference pricing 
of nonsteroidal 
anti-inflammatory 
drugs 
Yes 13 (for 
interve
ntion #2 
31) 
86 (for 
int. #2 
68) 
Monthl
y 
No Trend, 
autocor-
relation 
Linear regression 
Puig 
2007 
Reference pricing 
for generics  
Yes (but 
differing 
between 
sites & 
drugs) 
16 
(varies 
dependi
ng on 
site & 
drug) 
30(varies 
dependin
g on site 
& drug) 
Monthl
y 
No Trend, 
autocorr-
elation  
Generalised Least-Squares 
regression 
Smart 
1976 
Ban on alcohol 
advertisements 
Yes > 12 >12 Monthl
y 
Yes Trend Calculation of geometric mean 
consumption, t-test for 
comparison  
Makowk
sy 1991 
Lifting of an 
advertising ban on 
alcohol 
Yes 32 46 Monthl
y 
Yes Trend, 
autocor-
relation 
ARIMA (Box and Jenkins method) 
Khan 
2003 
Change in 
antibiotic policy 
and use of 
antibiotics  
Yes (diff. 
time 
points 
for 2 
separate 
interv.) 
6 (1st 
interve
ntion) 
12 (1st 
intervent
ion) 
Quarter
ly 
No - No statistical analysis 
Mercer 
1999 
Antibiotic control 
policy 
Yes 12 12 Monthl
y 
No - No statistical analysis  
Goldwat
er 1989 
Introduction of 
recapping device 
for needles 
Yes 9 36 Monthl
y 
No - No statistical analysis 
Sossai 
2010 
Sharps awareness 
campaign and 
needlestick 
prevention 
devices 
Yes 
(year) 
0 5 Yearly No - No statistical analysis 
Carpent
er 2011 
Anti-drug media 
campaign 
Yes 0 3 Na No  Multivariate logistic regression 
of post-intervention time 
Idaho 
Meth 
2011 
Messaging 
campaign on drug 
use 
Yes 1 3 Yearly No - No statistical analysis 
Jackevici
us 2001 
Publication of 
scientific evidence 
on medical 
practice 
Yes 32 28 Monthl
y 
No Trend, 
autocor-
relation  
Segmented regression analysis, 
linear regression 
Lam 
2009 
Publishing of large 
RCT about statins 
in nephrology 
Yes 33 7 Other No Autocor-
relation  
Linear regression to estimate 
annual increase in statin use and 
subsequent F-test to assess 
slope difference 
Beal 
2007 
Regulation on 
architectural 
design for 
construction sites 
Yes  14 10 Yearly No - No statistical analysis 
Lipscom
b 2003 
Washington State 
fall standard for 
the construction 
industry 
Yes 8 31 Quarter
ly 
No Trend  Poisson regression 
Joy 2007 Permissible 
exposure level 
(PEL) for noise 
exposure in coal 
mining  
Yes 12 5 Yearly No - Linear regression 
Rabinow
itz 2011 
Mandatory 
hearing protection 
programme 
Yes 
(year) 
5 4 Yearly Yes - Difference-in differences analysis 
based on individual-specific 
regression coefficients before 
and after the intervention 
4. Discussion 
4.1. Key findings 
In relation to our primary research question, we found a heterogeneous set of different study 
designs under the label ‘CBA’ and ‘ITS’ studies. Not all studies fitted the Cochrane definition of a CBA 
and ITS study. We found, for example, CBA studies without control sites as well as ITS studies without 
an intervention (‘the interruption’) included in Cochrane reviews. Some CBA studies did not comply 
with the EPOC criteria, e.g. because of an insufficient number of intervention and control sites; one 
ITS study had insufficient data points. Researchers were involved in the intervention allocation in 
almost half of all included CBA studies. According to EPOC-guidance, such studies should be classified 
as NRCTs. It is also noteworthy that there is a stark discrepancy between methods employed for data 
collection versus data analysis, where researchers often do not fully exploit the strength of the 
collected data in their analysis. Bad reporting, however, often precluded clear identification of the 
analysis methods. 
In relation to our secondary research questions, most Cochrane reviews that included CBA and ITS 
studies were concerned with interventions on an organisational level; few addressed interventions 
on a population level and, as expected, very few took place on an individual level. We did not find 
many reviews of typical public health interventions, for example environmental, vaccination or 
screening interventions, which would lend themselves to the use of CBA and ITS studies. 
There are striking differences among Cochrane reviews with respect to labelling and defining CBA 
and ITS studies. One third of the included reviews did not provide any criteria for the study designs.  
These findings were all the more surprising, given that our sample was drawn from the relatively 
homogeneous and strongly methodologically influenced Cochrane community. Our analysis thus 
confirms that the inconsistent use of terminology leads to confusion among systematic reviewers 
regarding what can be classified as an ITS or CBA study [8, 21, 71, 72]. 
On the primary study level the labels “CBA” and “ITS” appear infrequently; instead a large variety of 
terms is used. This suggests that CBA and ITS study labels and the study design characteristics 
associated with them are hardly used or known among primary study authors.  
 
4.2. Towards clearer CBA and ITS study definitions and criteria 
Considering the challenges we faced trying to categorize the CBA and ITS studies included in this 
analysis and considering the limited use of the study design labels in primary research, we explain in 
detail study characteristics and potentially problematic features.  
This discussion is intended to help review authors identify these study designs in the screening 
process; from our experience the definitions and criteria provided by Cochrane and Cochrane EPOC, 
while helpful, still leave much space for interpretation, a lack of clarity that is partially responsible for 
the heterogeneous findings of this study and previous studies [10, 15, 16, 19, 20]. This discussion is 
also intended to offer input towards consensual definitions and features of these study designs, 
which would eventually be helpful for both review authors and primary researchers.  
4.2.1. CBA studies 
Key characteristics 
According to EPOC and with some additional elaboration, a high quality CBA study (i) uses at least 
two intervention and two appropriate control sites, and (ii) employs contemporaneous data 
collection, whether carried out specifically for this purpose or using existing datasets, at relevant pre- 
and post-intervention time points at all sites. CBA studies may be prospective or retrospective in 
nature. The intervention effects can be analysed at cluster or individual level but the analysis should 
compare the difference in pre-post changes between intervention and control groups.  
Explanations  
Using two intervention and two control sites may be advantageous because study validity increases 
with more sites being used. With only one site per group, any difference in observed effect between 
the intervention and control group may simply be due to underlying differences in the characteristics 
of the two sites, where these characteristics may be measured, known but not measured or 
unknown. In circumstances, when more than two levels are involved, e.g. individuals or classes 
nested within schools and cities, it may be challenging to decide what constitutes the site [73]. 
Furthermore, should sites be actual locations (e.g. villages, schools) or can other clusters or groups of 
people (e.g. family members in a household or employees in a given company) form a site? This may, 
however, be irrelevant as long as the analysis takes the groups into account. The sites should have 
similar baseline characteristics, by choice or through matching; in case of baseline differences, an 
appropriate method of statistical adjustment should be applied. 
Whereas Cochrane EPOC [12] and Hartling et al. [15] acknowledge CBA studies as natural 
experiments, in the Cochrane handbook investigator control to some extent is not ruled out [11]. 
Deeks et al. [14] suggest that a CBA “can also be considered an experimental design if the 
investigator has control over, or can deliberately manipulate the introduction of the intervention”.  
The analysis should take into account the presence of a control group. A simple t-test comparing post 
changes between the groups may not suffice to show an intervention effect, particularly where 
baseline differences between the groups exist. The analysis should adjust for potential clustering 
effects where unit of observation and unit of analysis differ. More advanced methods, such as 
difference-in-differences analysis, adjusting for differences between the different sites, may better 
reflect the design. Such analysis methods have been widely applied in other disciplines, such as 
economics [74], and it would be beneficial to take on board lessons learnt.  
 
Differences and similarities in relation to other study designs 
CBA studies partially overlap with other study designs with implications for how these studies are 
searched for, described and appraised as well as synthesised in systematic reviews. The main 
difficulty lies in differentiating between cluster-NRCTs and CBA studies. One possibility is to use 
active intervention allocation by the investigator as the distinguishing feature between cluster-NRCTs 
(present) and CBA studies (absent; natural experiment); this approach has been adopted by 
Cochrane EPOC [12]. There are, however, cases where such a differentiation is difficult due to poor 
reporting and various interpretations of what to consider a natural experiment. Interestingly, 
Shadish, Cook and Campbell [75] do not distinguish between specific study design labels when 
describing “quasi-experimental designs that use both control groups and pretests”. Acknowledging 
CBA studies and cluster-NRCTs as part of a broader study design group without the necessity to 
identify the design more specifically may be another way forward. Differences in study design 
features could thus be articulated as part of the risk of bias assessment rather than as part of the 
study classification. 
 
4.1.1. ITS studies 
Key characteristics 
ITS studies are usually designed as natural experiments. They may be prospective or retrospective in 
nature and may include a control group (controlled ITS) [8, 15, 22]. As mentioned by Cochrane EPOC 
ITS studies should (i) use at least three data points before and three after the intervention, and (ii) 
clearly define the point in time, when the intervention occurred. An appropriate statistical analysis 
includes adjustment for secular trend. 
Explanations 
Although ITS studies are usually defined as natural experiments [12, 15], ITS studies can be used to 
assess interventions allocated by the investigators [76]. The EPOC threshold of three data points 
before and after the intervention is based on the reasoning that drawing a line through any fewer 
than three data points would estimate trend in a very unreliable way. Indeed, several recent studies 
suggest that sufficient statistical power is only achieved when at least eight data points are included; 
even more may be required when using ARIMA or segmented regression analysis [22, 24, 77]. 
Generally speaking, the precision of ITS studies increases with the number of data points. An 
unequivocal distinction between pre- and post-intervention and implementation time periods is 
critical; this also refers to multiple interventions implemented sequentially or staggered 
implementation of a given intervention in different groups, institutions or geographical areas [22]. 
Adding a control group further enhances the study’s validity and minimizes risk of bias [78]: Whereas 
an ITS study compares the post-intervention trend with a counterfactual (i.e. the prediction of what 
would have happened in case the intervention had not taken place estimated from pre-intervention 
trends), a controlled ITS study compares pre- and post-intervention time trends between an 
intervention and control group. Visualisation of data can help the reader interpret the study results 
[22, 23, 79] but can also be misleading and should therefore not be used routinely as a means of 
identifying or measuring an effect [80].  
The discrepancies between data collection and analysis in the included ITS studies highlight the 
importance of a statistical analysis that adjusts for secular trend [17, 19, 22, 24]. ARIMA or 
segmented regression models, which recognise secular trend as well as auto-correlation, are 
considered highly appropriate for analysing ITS data [19, 24, 79, 81]; other regression analyses may 
also be appropriate. Studies whose statistical analysis does not explicitly acknowledge secular trend 
(e.g. comparison of pre- and post- intervention means) or that merely display results graphically in 
fact miss the most important strength of the ITS design.  EPOC allows ITS studies with inappropriate 
analysis to be included in systematic reviews, provided the data are re-analysed.  This relies, 
however, partly on primary study authors providing their original data and is a time-consuming and 
resource-intensive process.  
Differences and similarities in relation to other study designs 
ITS studies are sometimes interchangeably listed as ‘time series’. However, a time series merely 
investigates an ordered sequence of values of a variable at equally spaced time intervals [82], 
whereas an ITS study is characterised by an interruption. ITS studies are also closely related to 
repeated measures studies, where measurements are made in the same individuals at each time 
point [12]. A further related study design is the regression discontinuity (RD) design, where different 
temporal occasions can be assigned to different treatment conditions [83].   
Especially with respect to controlled ITS studies, it may be hard for systematic reviewers to label 
these as an ITS study versus a CBA study.  As mentioned above, the essential feature of an ITS study 
is the statistical analysis, which must reflect multiple measurements over time and adjust for 
important secular trends. If this is not the case, a controlled ITS, with multiple measurements before 
and after the intervention, may be considered a CBA study.  
  
4.3. Strengths and weaknesses of this study 
We analysed a sample of CBA and ITS studies included in recent Cochrane reviews with respect to 
application and specific methodological characteristics. The sample was intended to be somewhat 
representative of the pre-specified types of interventions. Representativeness of findings is, 
however, limited, as we only selected two reviews per intervention type (where available) and two 
included studies from the selected reviews.  
At the primary study level, data extraction was done in duplicate and difficulties were extensively 
discussed among the data extractors and, where necessary, with the whole author team. As we did 
not re-analyse the studies, our insights reflect CBA and ITS studies as originally conducted, analysed 
and reported rather than according to their potential. In fact, we did not contact study authors for 
missing study details. Finally, the generalizability of our findings is probably limited to Cochrane 
reviews; we would expect to find even more variation in methodological characteristics of CBA and 
ITS studies outside of Cochrane.  
4.4. Recommendations for research and practice 
CBA and ITS studies are increasingly being recognised as important study designs that, if conducted 
and analysed well, can provide reliable effect estimates of the impacts of interventions, where 
randomisation is not feasible. Importantly, there is a need to further the understanding of the 
definitions and key characteristics of these study designs among primary researchers and systematic 
reviewers, including through textbooks of epidemiology and epidemiological curricula and beyond 
the field of epidemiology. Recently published research provides the first detailed guidance on how to 
conduct ITS studies [84]. However, CBA studies in particular almost appear to be “artificial study 
designs”, with the label created by systematic reviewers but little used in the primary research world. 
More specific definitions and key characteristics would be beneficial for systematic review authors in 
and outside of Cochrane to facilitate greater clarity with respect to including or excluding study 
designs. Further discussions should clarify when to include a CBA or ITS study according to EPOC 
criteria and when to include a study not meeting EPOC criteria but downgrade for risk of bias. This 
would minimise confusion and improve consistency within Cochrane and beyond. 
While we have summarized and explained important features and characteristics of CBA and ITS 
studies and initiated a discussion about key characteristics, key study design and analysis 
characteristics should be clarified and their definitions updated through a consensus process, such as 
a Delphi procedure. There are direct implications for risk of bias assessment for these study designs 
that will be developed as the ROBINS-I tool [85] is advanced for different study designs. The 
development of a new reporting guideline, for example, an extension of the Transparent Reporting 
of Evaluations with Nonrandomized Designs (TREND) statement [86] could be an important second 
step. Taken together, this could greatly advance methodological practice at primary study as well as 
systematic review level and ensure that CBA and ITS studies are put to the best use possible in 
evaluating the impacts of interventions.  
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